Item 8.01 Other Events.
Resumption of trading on the OTCQB
On March 9, 2021, the Financial Industry Regulatory Authority ("FINRA")
processed a Form 211 application relating to the initiation of priced quotations
of the common stock of Vitality Biopharma, Inc. (the "Company"). FINRA's
processing of a Form 211 in no way constitutes FINRA's approval of the Company's
common stock, the Company or the Company's business and relates solely to the
submitting broker-dealer's obligation to comply with FINRA Rule 6432 and Rule
15c2-11 promulgated under the Securities Exchange Act of 1934, as amended, when
quoting a security. As of March 10, 2021, the Company's common stock was quoted
on the OTC Link ATS. The Company has not yet obtained Depository Trust Company
eligibility for the Company's common stock but expects to do so in the near
future. The Company's common stock had been trading with limited liquidity on
the grey market since November 21, 2018. Grey market stocks are not traded or
quoted on an exchange or inter-dealer quotation system, but are reported by
broker-dealers to their self-regulatory organization who, in turn, distribute
the trade data to market data vendors and financial websites.
The information in this Item 8.01 is intended to be furnished and shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as
expressly set forth by specific reference in such filing.
© Edgar Online, source Glimpses